Podcast: Play in new window | Download (Duration: 6:08 — 14.0MB)
Subscribe: Apple Podcasts | Spotify | RSS
During the Asia-focused Episode 33 of Biotalk, Geoff Meyerson, CEO of Locust Walk, reviews key 2025 Year-In-Review trends across China, Japan, and […]
Podcast: Play in new window | Download (Duration: 11:24 — 26.1MB)
Subscribe: Apple Podcasts | Spotify | RSS
During Episode 32 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2025 Year-In-Review Report: Global Trends in Biopharma
Locust Walk conducted a multi‑year analysis of JPM‑week deal activity to evaluate whether early‑January partnering and M&A activity can reliably benchmark and anticipate full‑year dealmaking momentum across global biopharma.
Each quarter, Locust Walk’s deal team compiles key statistics and trends on strategic transactions and financings. Our 2025 Year-In-Review Report applies the latest data to analyze the current landscape in life sciences deals.
Podcast: Play in new window | Download (Duration: 4:44 — 10.8MB)
Subscribe: Apple Podcasts | Spotify | RSS
During Episode 31 of Biotalk, Geoff Meyerson, CEO of Locust Walk, explores Asia-Pacific biotech momentum across China, Japan, and Korea, as featured
Podcast: Play in new window | Download (Duration: 13:18 — 30.4MB)
Subscribe: Apple Podcasts | Spotify | RSS
During Episode 30 of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2025 Q3 Report: Global Trends in Biopharma
Align Summit 2025 Align Summit – October 7, 2025 Locust Walk co-hosted the third annual Align Summit in Boston, an
Each quarter, Locust Walk’s deal team compiles key statistics and trends on strategic transactions and financings. Our 2025 Q3 Report applies the latest data to analyze the current landscape in life sciences deals.
Thoughts from Geoff Meyerson This past two weeks I had the privilege of visiting Japan and China, hosted by Locust